Current Cancer Drug Targets
Home
Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
CONTENTS & ABSTRACTS
CONTACT US
Tuesday, August 15, 2017
Home
» » Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
12:25 AM
No comments
Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Email This
BlogThis!
Share to Twitter
Share to Facebook
← Newer Post
Older Post →
Home
0 comments:
Post a Comment
Social Profiles
Blogroll
Popular
Tags
Blog Archives
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
(no title)
Cancer Stem Cells: Are We Targeting the Right Cells?
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
Podcast for (Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies)
Podcast for (Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies)
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
Call For Paper
Call For Paper
Call For Paper
Call For Paper
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profile...
Blog Archive
►
2018
(3)
►
April
(1)
►
February
(1)
►
January
(1)
▼
2017
(36)
►
December
(1)
►
October
(4)
►
September
(1)
▼
August
(4)
Free Trial Offer
Most Accessed Article: CD20-based Immunotherapy of...
New Issue Published Current Cancer Drug Targets Vo...
Open Access Article:HR+, HER2– Advanced Breast Can...
►
July
(4)
►
June
(2)
►
May
(4)
►
April
(3)
►
March
(4)
►
February
(3)
►
January
(6)
►
2016
(24)
►
December
(6)
►
November
(4)
►
October
(8)
►
August
(1)
►
June
(5)
BTemplates.com
Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Pleiotropic Role of HSF1 in Neoplastic Transformation
0 comments:
Post a Comment